NIH boosts its clinical core

The National Institutes of Health is upgrading its drug development and manufacturing facility -- new location, new equipment, same mission -- to "help move ideas from the laboratory bench to the patient faster and better," said John Gallin, director of the NIH Clinical Center. Mark O. Hatfield Clinical Research CenterImage: National Institutes of HealthAs I toured the new $12 million, over 1,000 square meter facility today (March 25), I meandered through room after room of new, top of the lin

Jef Akst
Jef Akst

Jef Akst is managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.

View full profile.


Learn about our editorial policies.

Mar 24, 2010
The National Institutes of Health is upgrading its drug development and manufacturing facility -- new location, new equipment, same mission -- to "help move ideas from the laboratory bench to the patient faster and better," said John Gallin, director of the NIH Clinical Center.
Mark O. Hatfield Clinical Research Center
Image: National Institutes of Health
As I toured the new $12 million, over 1,000 square meter facility today (March 25), I meandered through room after room of new, top of the line equipment, high quality air filters, and easily cleanable epoxy flooring -- all aimed to better meet the US Food and Drug Administration's standards of good manufacturing practice (GMP). My tour comes just a few weeks after the NIH and FDA linkurl:announced a collaboration;http://www.the-scientist.com/blog/display/57174/ to increase efforts in translational and regulatory science. While the timing of the new partnership is purely "coincidental," Gallin said, the NIH did consult with...




Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?